The Global Oncology Information Systems Market Size accounted for USD 3.8 Billion in 2021 and is projected to occupy a market size of USD 7.5 Billion by 2030 growing at a CAGR of 7.9% from 2022 to 2030.
Oncology information systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall healthcare organizations. Furthermore, these advantages improve the efficiency and safety of cancer therapy for patients. Oncology information systems help surgeons and physicians to choose the most suitable therapy to develop the survival rate for cancer patients.
Oncology Information Systems Market Report Statistics
Global Oncology Information Systems Market Dynamics
Oncology Information Systems Market Report Coverage
|Market||Oncology Information Systems Market|
|Oncology Information Systems Market Size 2021||USD 3.8 Billion|
|Oncology Information Systems Market Forecast 2030||USD 7.5 Billion|
|Oncology Information Systems Market CAGR During 2022 - 2030||7.9%|
|Oncology Information Systems Market Analysis Period||2018 - 2030|
|Oncology Information Systems Market Base Year||2021|
|Oncology Information Systems Market Forecast Data||2022 - 2030|
|Segments Covered||By Product & Services, By Application, By End-User, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., and ViewRay Inc.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Oncology Information Systems Market Growth Factors
The key factors that drive the market growth include ease of use of different cancer therapies, such as radiation therapy, and chemotherapy, and the existence of a huge cancer population. During the envisaged period, the market is likely to witness moderate growth, due to the benefits offered by oncology information systems over conventional methods of record keeping and treatment planning. The factors that are anticipated to boost the market growth include the surge in the prevalence of cancer and rising in technological advancements, such as incorporation of patients portals. Furthermore, there are various opportunities for expanding markets such as the use of oncology information systems to treat rare cancer and advance improvements in the technology by the use of artificial intelligence. However, the factors likely to hinder the market growth include lack of healthcare IT professionals and high costs associated with oncology information systems.
Oncology Information Systems Market Segmentation
The global oncology information systems market is segmented based on product & services, application, and geography.
Oncology Information Systems Market By Product & Services
The global oncology information systems industry analysis, the solutions segment accounted for more than 2/3rd of the market share in 2021 and is likely to do so in the coming years. The large market share of this industry sector is primarily explained by the growing need to control the costs of oncology care, which are continuing to rise, and to enhance the effectiveness of oncology care services by lowering medical errors.
Oncology Information Systems Market By Application
According to the oncology information systems market forecast, the medical oncology application will account for a significant portion of the market from 2022 to 2030. Due to rapid advancements in hormonal therapy, immunotherapy, and targeted therapy for efficiently treating various cancers, the medical oncology segment is expected to grow at the fastest CAGR over the forecast period. During the forecast years, the surgical oncology segment is also expected to grow significantly. Cancer treatment has advanced rapidly in recent decades.
Oncology Information Systems Market By End-User
The hospitals & oncology clinics segment controlled the oncology information systems market in 2021 and is expected to continue dominating during the forecast period, owing to an increase in the number of cancer cases and patients visits to hospitals and clinics. End-user segments of the oncology information system market include hospitals and diagnostic imaging centers, ablation and cancer care centers, government institutions, and research facilities.
Oncology Information Systems Market Regional Outlook
The Middle East & Africa
Oncology Information Systems Market Regional Analysis
For each region, the market size and volume for different segments has been covered under the scope of report. North America region is accounted for the largest share of the oncology information systems market, followed by Europe in present years. Furthermore, the Asia-Pacific market is likely to grow at the highest CAGR during the upcoming period due to high growth can be attributed to the increasing focus of the market players on developing nations.
Oncology Information Systems Market Players
Some of the global oncology information systems companies included in the report are Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., and ViewRay Inc.
The market size of oncology information systems market in 2021 was accounted to be USD 3.8 Billion.
The projected CAGR of oncology information systems market during the analysis period of 2022 to 2030 is 7.9%.
The prominent players of the global oncology information systems payments transaction market include Elekta AB, Varian Medical Systems, Accuray Incorporated, Cerner Corporation, RaySearch Laboratories, Flatiron, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., and ViewRay Inc.
North America held the dominating oncology information systems during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for oncology information systems during the analysis period of 2022 to 2030.
Growing prevalence and incidence of cancer, increasing adoption of EHR and other healthcare IT solutions, and favorable government support and initiatives for oncology information systems drives the growth of global oncology information systems market.
Based on Product & Services, solutions segment is expected to hold the maximum share oncology information systems market.